User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 9 results.
    • Speech
    Arsenic trioxide in patients with myelodysplastic syndromes: A phase II multicenter study
    Vey, N Bosly, André[UCL] Guerci, A Feremans, W. Dombret, H. Dreyfus, F Bowen, D Burnett, A Dennis, M Ribrag, V. Casadevall, N. Legros, L Fenaux, P. (2006) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Speech
    Trisenox (R) (arsenic trioxide) in patients with myelodysplastic syndromes (MDS): Preliminary results of a phase I/II study.
    Vey, N Dreyfus, F Guerci, A Fenaux, P. Dombret, H. Burnett, AK. Bosly, André[UCL] Feremans, W. Bowen, DT Heiskala, M (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Speech
    Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult ALL patients - The LALA94 experience.
    Gabert, JA Picard, C. Hayette, S. Bilhou-Nabera, C. Cayuela, JM Macintyre, Elizabeth Frenoy, N. Preudhomme, C. Dupont, M. Bastard, C. Bories, D. Vaerman, JP. Davi, F. Dastugue, N. Raynaud, S. Lafage, M. Fest, T. Gaub, MP Lheritier, V. Thomas, X. Charrin, C. Boucheix, C. Dombret, H. Fiere, D. (2005) 47th Annual Meeting of the American-Society-of-Hematology — Atlanta(Ga)
    • Journal article
    Treatment of acute lymphoblastic leukemia in the elderly: An evaluation of interferon alpha given as a single agent after complete remission
    Delannoy, A. Cazin, B. Thomas, X. Bouabdallah, R. Boiron, J.M. Huguet, F. Straetmans, N.[UCL] Zérazhi, H. Vernant, J.P. Dombret, H. Bilhou-Nabera, C. Charrin, C. Boucheix, C. Sebban, C. Lhéritier, V. Fière, D. (2002) Leukemia and Lymphoma — Vol. 43, no. 1, p. 75-81 (2002)
    • Journal article
    A Controlled-study of Recombinant Human Granulocyte-colony-stimulating Factor in Elderly Patients After Treatment for Acute Myelogenous Leukemia
    Dombret, H. Ferrant, Augustin[UCL] Chastang, C. Fenaux, P. Reiffers, J. Bordessoule, D. Bouabdallah, R. Mandelli, F. Auzanneau, G. Tilly, H. Yver, A. Degos, L. (1995) New England Journal of Medicine — Vol. 332, no. 25, p. 1678-83 (1995)
    • Speech
    Trisenox (R) (arsenic trioxide) in patients with Myelodysplastic syndromes (MDS): Preliminary results of a phase 1/2 study.
    Vey, N Dreyfus, F Guerci, A Fenaux, P. Dombret, H. Burnett, A Bosly, André[UCL] Feremans, W. Bowen, D Garzon, F (2003) 45th Annual Meeting of the American-Society-of-Hematology — SAN DIEGO(California)
    • Journal article
    Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85,-87 and-94 trials
    Dhedin, N Dombret, H. Thomas, X. Lheritier, V. Boiron, JM Rigal-Huguet, F. Vey, N Kuentz, M Reman, O. Witz, F. Delannoy, André[UCL] Kovacsovics, T Bradstock, K Charrin, C. Boucheix, C. Gabert, J. Blaise, D Fiere, D. Vernant, JP. (2006) Leukemia — Vol. 20, no. 2, p. 336-344 (2006)
    • Journal article
    Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
    Callens, C Chevret, S Cayuela, JM Cassinat, B. Raffoux, E. de Botton, S Thomas, X. Guerci, A Fegueux, N Pigneux, A. Stoppa, AM Lamy, T Rigal-Huguet, F. Vekhoff, A Meyer-Monard, S Ferrand, A. Sanz, M Chomienne, C Fenaux, P. Dombret, H. (2005) Leukemia — Vol. 19, no. 7, p. 1153-1160 (2005)
    • Speech
    THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) IN THE IMATINIB ERA
    Delannoy, André[UCL] Delabesse, E. Lheritier, V. Castaigne, S. Rigal-Huguet, F. Raffoux, E. Garban, F. Legrand, O. Bologna, S. Dubruille, V. Turlure, Pascal Reman, O. Delain, M. Isnard, F. Coso, D. Raby, P. Buzyn, A. Cailleres, S. Darre, S. Fohrer, C. Sonet, Anne Bilhou-Nabera, C. Bene, M. -C. Dombret, H. Thomas, X. (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin (Germany)